Cargando…

FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia: A Low-Burden Disease with Dramatic Response to Imatinib - A Report of 5 Cases from South India

Objective: Eosinophilia associated with FIP1L1-PDGFRA rearrangement represents a subset of chronic eosinophilic leukemia and affected patients are sensitive to imatinib treatment. This study was undertaken to learn the prevalence and associated clinicopathologic and genetic features of FIP1L1-PDGFRA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Anıl N., Sathyanarayanan, Vishwanath, Devi, Visweswariah Lakshmi, Rajkumar, Namratha N., Das, Umesh, Dutt, Sarjana, Chinnagiriyappa, Lakshmaiah K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996631/ https://www.ncbi.nlm.nih.gov/pubmed/24764730 http://dx.doi.org/10.4274/Tjh.2013.0086

Ejemplares similares

Chronic eosinophilic leukemia with FIP1L1-PDGFRA rearrangement
por: Kim, Tae Hee, et al.
Publicado: (2016)

Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib
por: Kim, Dae Sik, et al.
Publicado: (2018)

FIP1L1-PDGFRA Clonal Hypereosinophilic Syndrome With Eosinophilic Myocarditis and Intracardiac Thrombus
por: Locke, Margaret, et al.
Publicado: (2023)

Long-term outcomes of imatinib in patients with FIP1L1/PDGFRA associated chronic eosinophilic leukemia: experience of a single center in China
por: Qu, Shi-Qiang, et al.
Publicado: (2016)

Pruritus as a Presenting Symptom of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia
por: Abu-Tineh, Mohammad, et al.
Publicado: (2021)

Chronic eosinophilic leukemia with FIP1L1-PDGFRA transcripts after occupational and therapeutic exposure to radiation
por: Balatzenko, Gueorgui, et al.
Publicado: (2011)

Identification of JAK2 as a Mediator of FIP1L1-PDGFRA-Induced Eosinophil Growth and Function in CEL
por: Li, Bin, et al.
Publicado: (2012)

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia
por: Shah, Shilpan, et al.
Publicado: (2014)

Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report
por: Yamamoto, Masayo, et al.
Publicado: (2017)

FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia
por: Loules, Gedeon, et al.
Publicado: (2009)

The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases
por: Legrand, Fanny, et al.
Publicado: (2013)

Chronic eosinophilic leukemia with a FIP1L1-PDGFRA rearrangement: Two case reports and a review of Korean cases
por: Shin, Sang-Yong, et al.
Publicado: (2015)

Generation of the Fip1l1–Pdgfra fusion gene using CRISPR/Cas genome editing
por: Vanden Bempt, M, et al.
Publicado: (2016)

Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia
por: Jain, Juhi, et al.
Publicado: (2020)

FIP1L1‐PDGFRA fusion gene in T‐lymphoblastic lymphoma: A case report
por: Ali, Salhah, et al.
Publicado: (2022)

Lyn mediates FIP1L1-PDGFRA signal pathway facilitating IL-5RA intracellular signal through FIP1L1-PDGFRA/JAK2/Lyn/Akt network complex in CEL
por: Li, Bin, et al.
Publicado: (2016)

Imatinib mesylate resistance and mutations: An Indian experience
por: Srivastava, Shweta, et al.
Publicado: (2013)

Ascites in a young male: idiopathic FIP1L1-PDGFRA-negative hypereosinophilic syndrome
por: Kasinathan, Ganesh, et al.
Publicado: (2020)

An Intriguing Case of Eosinophilia with FIP1L1/PDGFRA Rearrangement Who Presented as Thrombotic Thrombocytopenic Purpura
por: Alshehri, Hassan, et al.
Publicado: (2019)

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia
por: Helbig, Grzegorz, et al.
Publicado: (2011)

Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy
por: Chalmers, Z R, et al.
Publicado: (2015)

Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing
por: Mandelker, Diana, et al.
Publicado: (2015)

An intriguing case of a paravertebral extramedullary erythropoiesis presenting as tumor‐mimicking lesion in a patient with eosinophilia with FIP1L1‐PDGFRA rearrangement
por: Farah, Sassi, et al.
Publicado: (2022)

Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin
por: Jin, Yanli, et al.
Publicado: (2014)

KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib
por: Joensuu, Heikki
Publicado: (2023)

Correction to: Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin
por: Jin, Yanli, et al.
Publicado: (2021)

Dramatic response of an inoperable Merkel cell carcinoma with imatinib
por: Frenard, Cecile, et al.
Publicado: (2016)

An unusual case of Waldenstrom’s macroglobulinemia presented with nasopharyngeal involvement
por: Sathyanarayanan, Vishwanath, et al.
Publicado: (2013)

Impact of the KIT/PDGFRA genotype on prognosis in imatinib‐naïve Japanese patients with gastrointestinal stromal tumor
por: Cho, Haruhiko, et al.
Publicado: (2021)

Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era—experience from a tertiary oncology centre in Southern India
por: Kuntegowdanahalli, Lakshmaiah Chinnagiriyappa, et al.
Publicado: (2016)

Leukemogenic kinase FIP1L1‐PDGFRA and a small ubiquitin‐like modifier E3 ligase, PIAS1, form a positive cross‐talk through their enzymatic activities
por: Ibata, Makoto, et al.
Publicado: (2017)

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy
por: Ma, Rui, et al.
Publicado: (2019)

The Rab11 effectors Fip5 and Fip1 regulate zebrafish intestinal development
por: Jewett, Cayla E., et al.
Publicado: (2020)

Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy
por: Annaberdyev, Shohrat, et al.
Publicado: (2009)

Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells
por: Shen, Yingying, et al.
Publicado: (2014)

KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
por: Joensuu, Heikki, et al.
Publicado: (2023)

The Conformational Control Inhibitor of Tyrosine Kinases DCC-2036 Is Effective for Imatinib-Resistant Cells Expressing T674I FIP1L1-PDGFRα
por: Shen, Yingying, et al.
Publicado: (2013)

Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
por: Sathyanarayanan, Vishwanath, et al.
Publicado: (2014)

Imatinib dramatically alleviates pulmonary tumour thrombotic microangiopathy induced by gastric cancer
por: Kubota, Kana, et al.
Publicado: (2017)

Chitinase-1 Activity in Serum of Cats with FIP
por: Stranieri, Angelica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ns37c2tp5tn33hkc2ukl779el1